Title : NTERA-2
Text : [[File:NTERA-2_differentiation.png|thumb| NTERA-2 cells before (left) and after (right) differentiation induced by exposure to [[retinoic acid]]. The bottom panels show NTERA-2 cells expressing [[Glial fibrillary acidic protein|GFAP]], a neural precursor marker, after differentiation.|308x308px]]The '''NTERA-2''' (also designated '''NTERA2/D1,''' '''NTERA2''', or '''NT2''') cell line is a [[clone (cell biology)|clonally]] derived, [[pluripotent]] human [[embryonal carcinoma]] [[cell line]].<ref name="pmid2419526">{{cite journal|vauthors=Lee VM, Andrews PW | title=Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. | journal=J Neurosci | year= 1986 | volume= 6 | issue= 2 | pages= 514–21 | pmid=2419526 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2419526  }}</ref>

==Characteristics==
NTERA-2 cells exhibit biochemical and developmental properties similar to the cells of the early [[embryo]], and can be used to study the early stages of human [[neurogenesis]]. The cells exhibit a high [[Cell nucleus|nucleo]]-[[cytoplasm]]ic ratio, prominent [[nucleoli]], and the expression of the [[glycolipid]] [[antigen]] [[SSEA-3]]. They also express [[nestin (protein)|nestin]] and [[vimentin]], which are found in neuroepithelial [[precursor cell]]s, as well as [[microtubule-associated protein]]s expressed in human [[neuroepithelium]].<ref name="pmid8411264" /> NTERA-2 cells also accumulate cytoplasmic [[glycogen]].<ref name="pmid6694356">{{cite journal |vauthors=Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, etal | title=Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. | journal=Lab Invest | year= 1984 | volume= 50 | issue= 2 | pages= 147–62 | pmid=6694356 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6694356  }}</ref>

==Differentiation==
NTERA-2 cells [[Cellular differentiation|differentiate]] when exposed to [[retinoic acid]] and lose expression of SSEA-3. Differentiation produces [[neuron]]s via [[asymmetric cell division]], and these cells form interconnected [[axon]] networks and express [[tetanus toxin]] receptors and [[neurofilament]] proteins.<ref name="pmid6144603">{{cite journal| author=Andrews PW| title=Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. | journal=Dev Biol | year= 1984 | volume= 103 | issue= 2 | pages= 285–93 | pmid=6144603 | doi= 10.1016/0012-1606(84)90316-6| pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6144603  }}</ref> By 10–14 days of exposure to retinoic acid, NTERA-2 cells begin to take on the morphological characteristics of neurons, such as rounded cell bodies and [[Neuronal process|processes]].<ref name="pmid8411264">{{cite journal|vauthors=Pleasure SJ, Lee VM | title=NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. | journal=J Neurosci Res | year= 1993 | volume= 35 | issue= 6 | pages= 585–602 | pmid=8411264 | doi=10.1002/jnr.490350603 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8411264  }}</ref> NTERA-2 cells can also produce a small number of [[oligodendrocyte]]-type cells, but they cannot differentiate into [[astrocytes]].<ref name="pmid14550780">{{cite journal |vauthors=Marchal-Victorion S, Deleyrolle L, De Weille J, Saunier M, Dromard C, Sandillon F, etal | title=The human NTERA2 neural cell line generates neurons on growth under neural stem cell conditions and exhibits characteristics of radial glial cells. | journal=Mol Cell Neurosci | year= 2003 | volume= 24 | issue= 1 | pages= 198–213 | pmid=14550780 | doi= 10.1016/s1044-7431(03)00161-1| pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14550780  }}</ref>

==Research==
Because of their similarity to human [[embryonic stem cell]]s, NTERA-2 cells are used to study the [[dopaminergic]] differentiation of neuronal precursor cells.<ref name="pmid16305337">{{cite journal |vauthors=Schwartz CM, Spivak CE, Baker SC, McDaniel TK, Loring JF, Nguyen C, etal | title=NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. | journal=Stem Cells Dev | year= 2005 | volume= 14 | issue= 5 | pages= 517–34 | pmid=16305337 | doi=10.1089/scd.2005.14.517 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16305337  }}</ref> They have also been proposed as an in vitro test system for developmental [[neurotoxicity]].<ref name="pmid23917397">{{cite journal|vauthors=Stern M, Gierse A, Tan S, Bicker G | title=Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity. | journal=Arch Toxicol | year= 2014 | volume= 88 | issue= 1 | pages= 127–36 | pmid=23917397 | doi=10.1007/s00204-013-1098-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23917397  }}</ref>

==History==
NTERA-2 cells were originally isolated from a lung [[metastasis]] from a 22-year-old male patient with primary embryonal carcinoma of the [[testis]]. The tumor was [[xenograft]]ed onto a mouse, and from this cells were cloned into the NTERA-2 cell line.<ref name="pmid6694356"/>

==References==
{{reflist|2}}

==External links==
*[https://web.expasy.org/cellosaurus/CVCL_0034 Cellosaurus entry for NTERA-2]

[[Category:Human cell lines]]
[[Category:Stem cell research]]
